Works matching IS 19414390 AND DT 2009 AND VI 2 AND IP 1
Results: 25
Safety of bevacizumab in advanced ovarian and müllerian cancers: a review.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Con: Secondary surgical debulking is not an acceptable option in patients with recurrent platinum-sensitive ovarian cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Con: Patients with recurrent ovarian carcinoma should not be treated with antiangiogenic agents in combination with chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Debate: Treatment of patients with recurrent ovarian cancer with antiangiogenic agents in combination with chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Trial design strategies for vascular-targeted therapy of patients with ovarian cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
First reported activity of sunitinib in the context of platinum-resistant endometrioid ovarian cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Ovarian cancer in a man?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Is serum albumin an independent predictor of survival in ovarian cancer?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Is the adjustment of serum creatinine level from <LT>0.6 mg/dL to 0.6 mg/dL justified in estimating carboplatin clearance calculated by the Jelliffe formula?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Use of docetaxel after paclitaxel hypersensitivity reaction in epithelial ovarian and endometrial cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
A proposal to improve treatment of patients with gynecologic cancer in developing countries.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Getting personal! The treatment of epithelial ovarian cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
CON: Secondary Surgical Debulking Is Not an Acceptable Option in Patients with Recurrent Platinum-Sensitive Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 21, doi. 10.1016/S1941-4390(11)70055-1
- By:
- Publication type:
- Article
Debate: Secondary Surgical Debulking as an Acceptable Option in Patients with Recurrent Platinum-Sensitive Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 19, doi. 10.1016/S1941-4390(11)70054-X
- By:
- Publication type:
- Article
CON: Patients with Recurrent Ovarian Carcinoma Should Not Be Treated with Antiangiogenic Agents in Combination with Chemotherapy.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 16, doi. 10.1016/S1941-4390(11)70053-8
- By:
- Publication type:
- Article
Is the Adjustment of Serum Creatinine Level from < 0.6 mg/dL to 0.6 mg/dL Justified in Estimating Carboplatin Clearance Calculated by the Jelliffe Formula?
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 48, doi. 10.3816/COC.2009.n.007
- By:
- Publication type:
- Article
Ovarian Cancer in a Man?
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Use of Docetaxel After Paclitaxel Hypersensitivity Reaction in Epithelial Ovarian and Endometrial Cancer.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 44, doi. 10.3816/COC.2009.n.006
- By:
- Publication type:
- Article
A Proposal to Improve Treatment of Patients with Gynecologic Cancer in Developing Countries.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 38, doi. 10.3816/COC.2009.n.005
- By:
- Publication type:
- Article
Is Serum Albumin an Independent Predictor of Survival in Ovarian Cancer?
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 52, doi. 10.3816/COC.2009.n.008
- By:
- Publication type:
- Article
Trial Design Strategies for Vascular-Targeted Therapy of Patients with Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 24, doi. 10.3816/COC.2009.n.003
- By:
- Publication type:
- Article
Getting Personal! The Treatment of Epithelial Ovarian Cancer.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Clinical Ovarian Cancer.
- Published in:
- 2009
- By:
- Publication type:
- Table of Contents
Safety of Bevacizumab in Advanced Ovarian and Müllerian Cancers: A Review.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 31, doi. 10.3816/COC.2009.n.004
- By:
- Publication type:
- Article
Debate: Treatment of Patients with Recurrent Ovarian Cancer with Antiangiogenic Agents in Combination with Chemotherapy.
- Published in:
- Clinical Ovarian Cancer, 2009, v. 2, n. 1, p. 12, doi. 10.3816/COC.2009.n.002
- By:
- Publication type:
- Article